Overall survival and role of programmed death ligand 1 expression in patients with metastatic non-small-cell lung cancer and immunotherapy: an observational study from central Switzerland. Swiss Med Wkly [Internet]. 2023 Jan. 30 [cited 2025 Oct. 29];153(1):40039. Available from: https://www.smw.ch/index.php/smw/article/view/3290